Pancreatic Cancer Research

ResearcherStony Brook UniversityActive in the last 2 years

Kenneth Reed Shroyer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-8090-0778; OpenAlex author ID A5086099448, A5108230633. Sources: OpenAlex.

Their work

Papers
17 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
57
Papers, trials and grants by year

2019: 2 papers · 2020: 3 papers · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 3 papers · 2025: 1 paper · 2026: 5 papers

Papers 17

  1. Network divergence analysis identifies adaptive gene modules and two orthogonal vulnerability axes in pancreatic cancer. Co-author DOI 10.1002/1878-0261.70218↗
  2. Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-4534↗
  3. A KRT17/GATA6 hybrid state marks unique vulnerability to MYC in pancreatic cancer Last author DOI 10.21203/rs.3.rs-11519779/v1↗
  4. Continuous tissue fields organize immune composition in pancreatic cancer Co-author DOI 10.64898/2026.08.22.746444↗
  5. Keratin 17 Defines an Epithelial-Mesenchymal Transition-Associated Migratory Cell State in Pancreatic Ductal Adenocarcinoma Last author DOI 10.64898/2026.10.27.762113↗
  6. Advancing Precision Medicine in PDAC: An Ethical Scoping Review and Call to Action for IHC Implementation. Last author DOI 10.3390/cancers17121899↗
  7. Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial. Co-author DOI 10.1001/jamaoncol.2024.1575↗
  8. Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/ajcp/aqae038↗
  9. Keratin 17 modulates the immune topography of pancreatic cancer. Last author DOI 10.1186/s12967-024-05252-1↗
  10. Targeting keratin 17-mediated reprogramming of de novo pyrimidine biosynthesis to overcome chemoresistance in pancreatic cancer Co-author DOI 10.1101/2022.08.24.504873↗
  11. Disassembly of embryonic keratin filaments promotes pancreatic cancer metastases Co-author DOI 10.1101/2022.08.27.504988↗
  12. Keratin 17 testing in pancreatic cancer needle aspiration biopsies predicts survival. Last author DOI 10.1002/cncy.22438↗
  13. An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer. Last author DOI 10.1002/1878-0261.12743↗
  14. Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2020.05.010↗
  15. Correction: Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer. Co-author DOI 10.1038/s41416-020-0879-6↗
  16. Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer. Co-author DOI 10.1038/s41416-018-0298-0↗
  17. Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer. Co-author DOI 10.1038/s41598-019-47519-4↗

Closest collaborators

The 25 strongest of 57 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Luisa F. Escobar‐Hoyos · 14 shared papers, 2019–2026 · strength 2.44
  2. Lyanne Delgado Coka · 8 shared papers, 2024–2026 · strength 1.90
  3. Lucia Roa‐Peña · 8 shared papers, 2019–2026 · strength 1.37
  4. Scott Powers · 4 shared papers, 2026 · strength 1.03
  5. Shayan Sarkar · 3 shared papers, 2026 · strength 0.75
  6. Chun‐Hao Pan · 6 shared papers, 2019–2026 · strength 0.74
  7. Minsig Choi · 3 shared papers, 2019–2024 · strength 0.36
  8. Nina V. Chaika · 2 shared papers, 2022–2026 · strength 0.34
  9. Pankaj Kumar Singh · 2 shared papers, 2022–2026 · strength 0.34
  10. Emanuel F. Petricoin · 2 shared papers, 2024 · strength 0.33
  11. Andrew Eugene Hendifar · 2 shared papers, 2024 · strength 0.33
  12. Brent K. Larson · 2 shared papers, 2024 · strength 0.33
  13. Wei Jiang · 2 shared papers, 2024 · strength 0.33
  14. Lynn McCormick Matrisian · 2 shared papers, 2024 · strength 0.33
  15. Brian Nelson · 1 shared paper, 2026 · strength 0.29
  16. Richard A. Moffitt · 3 shared papers, 2019–2020 · strength 0.28
  17. Mikala Egeblad · 1 shared paper, 2026 · strength 0.27
  18. Weihao Wang · 1 shared paper, 2026 · strength 0.27
  19. Marie C. Hasselluhn · 1 shared paper, 2026 · strength 0.27
  20. Mara H. Sherman · 1 shared paper, 2026 · strength 0.27
  21. Despina Siolas · 1 shared paper, 2026 · strength 0.27
  22. Ryan R. Kawalerski · 2 shared papers, 2020–2022 · strength 0.24
  23. Emanuel F. Petricoin · 1 shared paper, 2026 · strength 0.21
  24. David Arthur Tuveson · 1 shared paper, 2026 · strength 0.21
  25. Jeffrey L. Vacirca · 2 shared papers, 2019–2020 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.